KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Total Current Liabilities (2018 - 2025)

Twist Bioscience (TWST) has disclosed Total Current Liabilities for 6 consecutive years, with $72.1 million as the latest value for Q1 2023.

  • On a quarterly basis, Total Current Liabilities fell 14.8% to $72.1 million in Q1 2023 year-over-year; TTM through Mar 2023 was $72.1 million, a 14.8% decrease, with the full-year FY2022 number at $90.7 million, up 43.79% from a year prior.
  • Total Current Liabilities was $72.1 million for Q1 2023 at Twist Bioscience, down from $90.7 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $90.7 million in Q3 2022 to a low of $18.6 million in Q1 2019.
  • A 5-year average of $51.1 million and a median of $47.6 million in 2021 define the central range for Total Current Liabilities.
  • Peak YoY movement for Total Current Liabilities: soared 204.47% in 2019, then dropped 14.8% in 2023.
  • Twist Bioscience's Total Current Liabilities stood at $57.8 million in 2019, then crashed by 37.71% to $36.0 million in 2020, then surged by 122.14% to $80.0 million in 2021, then grew by 13.28% to $90.7 million in 2022, then dropped by 20.47% to $72.1 million in 2023.
  • Per Business Quant, the three most recent readings for TWST's Total Current Liabilities are $72.1 million (Q1 2023), $90.7 million (Q3 2022), and $84.6 million (Q1 2022).